-100
NPS
Learn More about Brand Intelligence Solutions
Find out what hundreds of thousands of customers are saying about your brand, your competitors and others in the industry
Thank you for inquiring about Comparably's Brand Intelligence Solutions
A member from Comparably's team member will be reaching out shortly to set up a time to speak about our Brand Intelligence Solutions
Brand Page
FibroGen
Marketing or Exec? Claim Your Free Account
About FibroGen's Brand
FibroGen, a research-based biotech firm, uses its expertise CTGF and HIF biology to discover, develop, and commercialize novel therapeutics. Among its major competitors, FibroGen is ranked in 4th place for NPS while Bristol Myers Squibb is 1st, and GlaxoSmithKline is 2nd.Their current market cap is $1.60B
Brand at a Glance
1.5/5
Product Quality
1.5/5
Pricing
FibroGen Ranking
- #4 / 4 of its competitors
FibroGen NPS
FibroGen's Net Promoter Score (NPS) is a -100 with 0% Promoters, 0% Passives, and 100% Detractors. Net Promoter Score tracks whether FibroGen's customers would recommend using the product based on a scale of -100 to 100.
FibroGen Overall NPS
| 0% | Promoters |
|---|---|
| 0% | Passives |
| 100% | Detractors |
FibroGen NPS Trend
-100
-50
0
50
100
| Summary | Date | Score |
|---|---|---|
Nov 2022 -100 | Nov 2022 | -100 |
How Other Brands Compare
FibroGen is ranked #4 for NPS among its competitors. Bristol Myers Squibb and GlaxoSmithKline come in first and second, with Astrazeneca PLC coming in at third. Among those competitors, it is the lowest valued company behind Astrazeneca PLC.
FibroGen |  Bristol Myers Squibb |  Astrazeneca PLC |  GlaxoSmithKline | |
| Global Ranking | #- | #205 | #511 | #- |
| NPS | -100 | 27 | 18 | 23 |
| Social Sentiment Calculated by analyzing social media and other online mentions | - | Neutral | - | - |
| Valuation Updated every 24 hours for public companies | $1.60B | $140.58B | $230.15B | $90.11B |
What is NPS
Net Promoter Score (NPS) is a management tool that can be used to gauge the satisfaction of a firm's customer relationships. NPS has been widely adopted as a key metric often linked to the revenue potential of a company’s product or service. The metric is based on customer responses to the question: "On a scale of 0 to 10, how likely are you to recommend the product to a friend?"
Those who respond with a score of 9 to 10 are known as Promoters, and are widely associated with behaviors that create value, including actively encouraging others to use the product or service. Those who respond with a score of 7 or 8 are categorized as Passives, and they are believed to be less likely to exhibit the value-creation traits of Promoters having a largely neutral effect on other consumers. Detractors are those who fall in the score range of 0 to 6 and represent dissatisfied customers of the product sometimes actively recommending against using the product.
FibroGen NPS vs. Competitors
Compared to its competitors, FibroGen's NPS is rated right below Akebia Therapeutics.
| COMPANY | NPS Score | |
|---|---|---|
| Bristol Myers Squibb | 27 |
| GlaxoSmithKline | 23 |
| Astrazeneca PLC | 18 |
 | Akebia Therapeutics | N/A |
| FibroGen | -100 |
FibroGen Product Quality
1.5/5
FibroGen has an overall Product Quality score of 1.5 out of 5 stars rated by its users and customers.
Sign Up to unlock FibroGen's overall Product Quality score rated by its users and customers.
FibroGen Product Information
FibroGen’s product quality score is a 1.5 out of 5 as rated by its users and customers.
- Website
- http://www.fibrogen.com
- Company Size
- 201-500 Employees
Industry
Tech
Biotech and Pharmaceuticals
Consumer Services
Healthcare
FibroGen Product Quality vs. Competitors
Compared to its competitors, FibroGen's Product Quality score is rated right above Akebia Therapeutics, and is preceded by Bristol Myers Squibb.
| COMPANY | Product Quality Score | |
|---|---|---|
| GlaxoSmithKline | 4/5 |
| Astrazeneca PLC | 4/5 |
| Bristol Myers Squibb | 3.9/5 |
| FibroGen | 1.5/5 |
| Akebia Therapeutics | N/A |
Unlock FibroGen Product Quality vs. Competitors Data
VS
Sign Up for Brand Profile PRO to get the full FibroGen Product Quality vs. Competitors data and gain insights into your customers today.
FibroGen Pricing
FibroGen ROI & Value For Money
1.5/5
FibroGen has a value for money and ROI score of 1.5 out of 5 stars rated by its users and customers.
Sign Up to unlock FibroGen's overall ROI score rated by its users and customers.
FibroGen Pricing vs. Competitors
Compared to its competitors, FibroGen's ROI score is rated right above Akebia Therapeutics, and is preceded by Bristol Myers Squibb.
| COMPANY | Pricing Score | |
|---|---|---|
| GlaxoSmithKline | 3.9/5 |
| Astrazeneca PLC | 3.9/5 |
| Bristol Myers Squibb | 3.7/5 |
| FibroGen | 1.5/5 |
| Akebia Therapeutics | N/A |
Unlock FibroGen ROI vs. Competitors Data
VS
Sign Up for Brand Profile PRO to get the full FibroGen ROI vs. Competitors data and gain insights into your customers today.
FibroGen Customer Satisfaction (CSAT)
Very Satisfied
0%
Satisfied
0%
Neither Satisfied nor Dissatisfied
0%
Dissatisfied
0%
Very Dissatisfied
100%
What is Customer Satisfaction (CSAT) Score
Customer Satisfaction Score (also known as CSAT), is a metric used to quantify how satisfied customers are with a company or brand’s products and services. The Customer Satisfaction Score is based on customers response to the question: “How would you rate your overall satisfaction with the service you received?” The score is calculated using the formula: (The total number answer of “Very Satisfied” and “Satisfied”) ÷ (The total response) x100, and it is generally displayed in percentages. Some of the main benefits of the CSAT for businesses are tracking retention, identifying happy customers and growing relationships, and gaining repeat business to build a sustainable brand.
FibroGen Customer Satisfaction vs. Competitors
Compared to its competitors, FibroGen's Customer Satisfaction score is rated right above Akebia Therapeutics, and is preceded by Bristol Myers Squibb.
| COMPANY | Customer Satisfaction (CSAT) Score | |
|---|---|---|
| Astrazeneca PLC | 83% |
| GlaxoSmithKline | 80% |
| Bristol Myers Squibb | 79% |
| FibroGen | 0% |
| Akebia Therapeutics | 0% |
Unlock FibroGen Customer Satisfaction vs. Competitors Data
VS
Sign Up for Brand Profile PRO to get the full FibroGen Customer Satisfaction vs. Competitors data and gain insights into your customers today.
Consumer vs. Employees
FibroGen scored a -100 for Net Promoter Score and a 0 for Employee Net Promoter Score. NPS gauges how likely a customer of FibroGen would recommend the brand to a friend. ENPS measures how likely FibroGen employees would recommend working at FibroGen to a friend.
Net Promoter Score
-100
NPS Score
| 0% | Promoters |
|---|---|
| 0% | Passive |
| 100% | Detractors |
Employee Net Promoter Score
0
eNPS Score
| 0% | Promoters |
|---|---|
| 100% | Passive |
| 0% | Detractors |
